BNBX
BNB PlusยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BNBX
Bnb Plus Corp.
Leader based on polymerase chain reaction("PCR")technology
50 Health Sciences Drive
Stony Brook
New York 11790
--
BNB Plus Corp. was incorporated under the laws of the State of Nevada on September 16, 2002. Formerly Applied DNA Sciences, Inc. BNB Plus Corp. is a biotechnology company that develops technologies for the production and detection of deoxyribonucleic acid. Using polymerase chain reaction to achieve DNA production and detection, the company operates in three main business markets: (i) DNA manufacturing for nucleic acid-based therapy; (ii) DNA testing for molecular diagnostic and genetic testing services; and (iii) DNA manufacturing and testing for industrial supply chain security services.
Company Financials
EPS
BNBX has released its 2025 Q2 earnings. EPS was reported at -15.35, versus the expected -3, missing expectations. The chart below visualizes how BNBX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BNBX has released its 2025 Q3 earnings report, with revenue of 304.39K, reflecting a YoY change of -35.62%, and net profit of -3.98M, showing a YoY change of -315.42%. The Sankey diagram below clearly presents BNBX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
